期刊文献+

糖皮质激素辅助用于急性加重期慢阻肺对患者动脉血气指标的影响分析 被引量:19

Effect of glucocorticoid on aterial blood gas indexes in patients with acute exacerbation of chronic obstructive pulmonary disease
原文传递
导出
摘要 目的分析急性加重期慢阻肺治疗中应用糖皮质激素的效果及对患者动脉血气指标的影响。方法选取我院2011年1月至2013年12月间收治的急性加重期慢阻肺患者84例,随机分为对照组和观察组,对照组给予特布他林,观察组在对照组基础上给予丙酸氟替卡松气雾剂,比较两组治疗效果。结果观察组治疗总有效率95.24%,明显高于对照组的73.81%;治疗后患者FEV1/FVC、FEV1预计值、PEF改善程度均明显优于对照组;PaO2、PaCO2指标结果优于对照组(P均<0.05)。结论急性加重期慢阻肺治疗中加用糖皮质激素可有效改善患者肺功能及动脉血气指标,提高治疗效果,值得临床推广应用。 Objective To analyze the effect of glucocorticoid on acute exacerbation of chronic obstructive pulmonary disease( COPD) period and its effect on blood gas indexes. Methods Eighty-four patients with acute exacerbation of COPD who were admitted in our hospital from 2011 January to 2013 December were selected and randomly divided into control group and observation group.The control group was given terbutaline,and the observation group were given Fluticasone Propionate Aerosol extra besides the drug of control group based. The treatment effects of the two groups were compared. Results The total effective rate of treatment group was 95. 24%,which was significantly higher than that of control group( 73. 81%). The FEV1 / FVC,FEV1 and PEF change of patients significantly better improved than the control group after treatment; the effect of Pa O2,Pa CO2 improvements were also better than that of control group( P〈 0. 05). Conclusion Applying glucocorticoid in the treatment of COPD can effectively improve the pulmonary function and arterial blood gas index and enhance the therapeutic effect,so it is worthy of clinical application.
作者 宋戈
出处 《临床医学》 CAS 2015年第2期43-44,共2页 Clinical Medicine
关键词 糖皮质激素 急性加重期慢阻肺 动脉血气指标 Glucocorticoid Acute exacerbation of chronic obstructive pulmonary disease Blood gas
  • 相关文献

参考文献7

二级参考文献79

  • 1有创-无创序贯机械通气多中心研究协作组.以肺部感染控制窗为切换点行有创与无创序贯机械通气治疗慢性阻塞性肺疾病所致严重呼吸衰竭的随机对照研究[J].中华结核和呼吸杂志,2006,29(1):14-18. 被引量:279
  • 2冉丕鑫,王辰,姚婉贞,陈萍,康健,黄绍光,陈宝元,王长征,倪殿涛,周玉民,刘升明,王小平,王大礼,吕嘉春,郑劲平,钟南山.我国部分农村地区40岁以上女性慢性阻塞性肺疾病危险因素分析[J].中华内科杂志,2006,45(12):974-979. 被引量:51
  • 3Barnes PJ.Inhaled corticosteroids are not beneficial in chronic obstructive pulmonary disease[J].Am J Respir Crit Care Med,2000,161(2Pt1):342-344.
  • 4Ito K,Yamamura S,Essilfie-Quaye S,et al.Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-kappaB suppression[J].J Exp Med,2006,203(1):7-13.
  • 5Barnes PJ,Adcock IM,Ito K.Histone acetylation and deacetylation:importance in inflammatory lung diseases[J].Eur Respir J,2005,25(3):552-563.
  • 6Ito K,Charron CE,Adcock IM.Impact of protein acetylation in inflammatory lung diseases[J].Pharmacol Ther,2007,116(2):249-265.
  • 7Montuschi P,Collins JV,Ciabattoni G,et al.Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers[J].Am J Respir Crit Care Med,2000,162(3Pt1):1175-1177.
  • 8Cosio BG,Tsaprouni L,Ito K,et al.Theophylline restores histone deacetylase activity and steroid responses in COPD macrophages[J].J Exp Med,2004,200(5):689-695.
  • 9Ito K,Lim S,Caramori G,et al.A molecular mechanism of action of theophylline:Induction of histone deacetylase activity to decrease inflammatory gene expression[J].Proc Natl Acad Sci USA,2002,99(13):8921-8926.
  • 10GOLD Executive Committee[DB/OL].Guidelines:Global Strategy for Diagnosis,Management,and Prevention of COPD,November 2006[2006-11-18].http://www.goldcopd.com/Guidelineitem.asp? l1 =2-12 = 1&intId =989.

共引文献8531

同被引文献73

引证文献19

二级引证文献178

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部